Science Explorer Back to mapMap
Discussion
Researcher · Chinese PLA General Hospital · China

Hanren Dai

Hanren Dai publishes mostly in Oncology, Immunology and Molecular Biology, on topics such as CAR-T cell therapy research, Immune Cell Function and Interaction and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0001-7662-511X OpenAlex
World rank
#179,440
of 7,710,434 ranked researchers
Rank in China
#17,744
of 978,568
Works
96
Citations
5.4k
Citations per work
56.0
h-index
29
i10-index 39Top 12% in Oncology
Hanren Dai

What does Hanren Dai research?

Hanren Dai's work is mostly in Medicine (36%), Immunology and Microbiology (22%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 34 works · 35.6% of their workMedicine: 34 works · 35.6% of their workOncology: 31 works · 32.2% of their workPathology and Forensic Medicine: 3 works · 3.4% of their workLife Sciences: 32 works · 33.3% of their workImmunology and Microbiology: 22 works · 22.4% of their workImmunology: 22 works · 22.4% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 10.9% of their workMolecular Biology: 7 works · 6.9% of their workGenetics: 4 works · 4.0% of their workEverything else: 27 works · 27.7% of their workPhysical Sciences: 3 works · 3.4% of their workEngineering: 3 works · 3.4% of their workElectrical and Electronic Engineering: 3 works · 3.4% of their workTHEIR WORKHanren Dai96works
Life Sciences33%Physical Sciences3%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3435.6%
    1. Immunology and Microbiology2222.4%
    2. Biochemistry, Genetics and Molecular Biology1010.9%
  3. Everything else2727.7%
    1. Engineering33.4%
  1. 1Oncology32% of their works
  2. 2Immunology22% of their works
  3. 3Molecular Biology7% of their works
  4. 4Genetics4% of their works
  5. 5Pathology and Forensic Medicine3% of their works
  6. 6Electrical and Electronic Engineering3% of their works

Research topics

Which keywords describe Hanren Dai's research?

The keywords of their largest research topics: Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells, NK Cell Recognition, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Immunotherapy442 topics
  2. Lymphoma442 topics
  3. CAR T Cells391 topic
  4. Chimeric Antigen Receptor391 topic
  5. NK Cell Recognition231 topic
  6. Natural Killer Cells231 topic
  7. Immune Checkpoint Blockade81 topic
  8. PD-1 and PD-L181 topic
  9. Gene Therapy61 topic
  10. Viral Vectors61 topic
  11. Cancer Stem Cells51 topic
  12. Classification51 topic
  13. Dendritic Cells51 topic
  14. Immunity51 topic
  15. Mesenchymal Stem Cells51 topic
  16. Molecular Profiling51 topic
  17. Multipotent51 topic
  18. Tumor Metastasis51 topic

Where does Hanren Dai work?

Hanren Dai's main affiliation in the publication record is Chinese PLA General Hospital, China.

How many publications and citations does Hanren Dai have?

OpenAlex counts 96 works and 5,379 citations for Hanren Dai, an h-index of 29, ranking #179,440 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hanren Dai. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.